Open Access

Erratum to: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus

Diabetology & Metabolic Syndrome20102:57

DOI: 10.1186/1758-5996-2-57

Received: 24 August 2010

Accepted: 25 August 2010

Published: 25 August 2010

The original article was published in Diabetology & Metabolic Syndrome 2010 2:16

Correction

Since publication of our article [1], we have noticed that amendments to the second sentence of the "Study Design" section are required as this should read as follows:

"Approved by the local ethics committee, patient enrolment was restricted to the following patients: those aged 18 years and greater and taking immediate release metformin alone or in combination with other oral agents, those excluded had symptoms of poor diabetes control, were pregnant, had serum creatinine levels >1.3 mg/dL (female) or 1.4 mg/dL (male), nephropathy, evidence of hepatic disease or history of alcohol abuse."

We apologize for any inconvenience or confusion that this may have caused.

Notes

Authors’ Affiliations

(1)
Department of Medicine, Diabetes Unit, State University of Rio de Janeiro

References

  1. Levy J, Cobas RA, Gomes MB: Assessment of efficacy and tolerability of once-daily extended release metformin in patients with type 2 diabetes mellitus. Diabetol Metab Syndr. 2010, 2: 16-10.1186/1758-5996-2-16.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Levy et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement